Recent Synthesis of Lipid A and Its Derivatives Monophosphoryl Lipid A

Lipid A, the hydrophobic anchor of lipopolysaccharide in the outer membrane of Gram-negative bacteria, serves as its principal immunostimulatory center. Variations in acyl chain numbers and lengths, phosphorylation status, and substituent groups directly influence the immunological responses elicited by this molecule. A representative example is monophosphoryl lipid A (MPLA), a dephosphorylated derivative of lipid A. This 1-O-dephosphorylated variant largely preserves the immunostimulatory strength of lipid A while showing substantially lower toxicity─a property that has made it clinically successful as a vaccine adjuvant. The synthesis of lipid A and its derivatives has attracted extensive attention from synthetic chemists. Understanding the structure-activity relationships (SARs) of these molecules has therefore remained a central goal in the field. However, systematic SAR work and the creation of structurally defined variants depend on reliable synthetic access, which continues to pose significant difficulties. In particular, the stereoselective assembly of the diglucosamine core and the precise installation of diverse acyl and phosphate groups present substantial synthetic hurdles. While numerous synthetic routes have emerged for lipid A and its derivatives over the past few decades, a general and effective method for assembling the diglucosamine core remains to be established. This review systematically summarizes these synthetic advances, with a particular emphasis on rational design and structural considerations. We highlight strategies and concepts developed to address key chemoselective, stereoselective, and enantioselective challenges during assembly of the characteristic bisphosphorylated β-(1→6)-linked diglucosamine backbone. Finally, we outline the fundamental relationships between unique molecular conformations of lipid A and their resulting biological activities. This review provides theoretical guidance for designing rational synthetic routes of novel lipid A and its derivatives MPLA, selectively regulating stereoselectivity issues, and the development of targeted, more effective immunotherapies and vaccine adjuvants.